ecancer

Comment: Kidney surgery may be unneeded in many intermediate-risk patients

Dr Sumanta Pal & Prof Richard Schilsky

3 Jun 2018

Editor’s Choice for May 2018

Prof Gordon McVie - Founding Editor, ecancer

21 May 2018

Editor's Choice for April 2018

Prof Gordon McVie - Founding Editor, ecancer

27 Apr 2018

Phase I taselisib results and a cell-free DNA assay

Dr José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA

25 Apr 2018

One off PSA prostate screening for men does not save lives

Prof Richard Martin - University of Bristol, Bristol, UK

29 Mar 2018

The Integrative Cancer Epidemiology Programme

Prof Richard Martin - University of Bristol, Bristol, UK

29 Mar 2018

Editor’s Choice for March 2018

Prof Gordon McVie - Founding Editor, ecancer

29 Mar 2018

Management of marker negative stage II testicular cancer

Dr Christian Kollmannsberger - University of British Columbia, Vancouver, Canada

16 Mar 2018

Editor's Choice for February 2018

Prof Gordon McVie - Founding Editor, ecancer

26 Feb 2018

Durvalumab plus tremelimumab or durvalumab monotherapy in metastatic urothelial carcinoma

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA

9 Feb 2018

Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma

Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada

9 Feb 2018

Genetic mutations: New therapeutic avenues in metastatic prostate cancer

Dr Joaquin Mateo - Vall d'Hebron Institute of Oncology, Barcelona, Spain

9 Feb 2018

More from ecancer